<p>OL8 or OL8(3.5Y) cells were cultured in the presence of 100 μM RBV for 5 to 10 weeks. The obtained RBV-survived colonies were named OL8(3.5Y)R. The mixed OL8(3.5Y)R cells were further treated with RBV increasingly, step by step, at final concentrations of 100, 150, and 200 μM, resulting in 12 independent RBV-survived colonies (named R200#1 to R200#12). Three colonies, R200#1, R200#8, and R200#11, were further analyzed as representative RBV-resistant cell lines.</p
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
<div><p>Background</p><p>Ribavirin (RBV) is a potential partner of interferon-based therapy and rece...
Background Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved ...
<p>(A) R200#1, R200#8, R200#11, and OL8(3.5Y) cells were treated with RBV (25, 50, and 100 μM) for 3...
<p>(A) Quantitative analysis of intracellular genome-length HCV RNA. The total RNAs from OL(4Y), OL8...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
Background The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable d...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
<p>(A) Schematic representation of construction of the HCV genome and the sites of adaptive mutation...
Abstract Background Given the side effects associated with intravenous injections of interferon, an ...
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
<div><p>Background</p><p>Ribavirin (RBV) is a potential partner of interferon-based therapy and rece...
Background Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved ...
<p>(A) R200#1, R200#8, R200#11, and OL8(3.5Y) cells were treated with RBV (25, 50, and 100 μM) for 3...
<p>(A) Quantitative analysis of intracellular genome-length HCV RNA. The total RNAs from OL(4Y), OL8...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
Background The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable d...
The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and v...
<p>(A) Schematic representation of construction of the HCV genome and the sites of adaptive mutation...
Abstract Background Given the side effects associated with intravenous injections of interferon, an ...
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Hepatitis C Virus (HCV) is the major causative agent of Non-A, Non-B Hepatitis (NANBH) worldwide. It...
Persistent hepatitis C virus (HCV) infection frequently causes hepatocellular carcinoma. However, t...